We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

CNP:NYSECenterPoint Energy, Inc (Holding Co) Analysis

Data as of 2026-05-20 - not real-time

$42.50

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

CenterPoint Energy trades at $42.5, just above its 20‑day SMA of 42.58 and below the 50‑day SMA of 42.85, indicating a modestly bullish short‑term bias but still within a neutral zone. The RSI of 49.6 confirms a lack of overbought or oversold pressure, while the MACD histogram of –0.06 and bearish signal line suggest a slight downside tilt in the next few weeks.
Fundamentally, the company posted 1.9% revenue growth, maintains a healthy gross margin of 45.9% and operating margin of 21.9%, and its forward EPS of $2.08 translates to a forward P/E of 20.4, roughly in line with the industry average P/E of 21.5. The dividend yield of 2.16% with a 54% payout ratio appears sustainable given positive operating cash flow, and analysts (16) collectively rate the stock as a Buy with a mean target price of $46.13, implying upside potential of about 8.5%. Recent Q1 results were described as “robust” and reaffirmed full‑year guidance, reinforcing confidence in the Texas‑focused growth pipeline. Overall, the stock sits at a fair valuation, offers modest dividend income, and presents a balanced risk‑reward profile for investors.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish MACD signal
  • Price hovering near resistance at $44.06
  • Stable trading volume

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Robust Q1 earnings and reaffirmed guidance
  • Forward P/E of 20.4 aligns with industry
  • Sustainable dividend yield of 2.16%

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Regulated utility business model provides stable cash flows
  • Growth pipeline in Texas and natural gas segments
  • Reasonable valuation relative to peers and attractive dividend

Key Metrics & Analysis

Financial Health

Revenue Growth1.90%
Profit Margin11.38%
P/E Ratio26.1
ROE9.56%
ROA2.84%
Debt/Equity215.59
P/B Ratio2.4
Op. Cash Flow$2.4B
Free Cash Flow$-4945375232
Industry P/E21.5

Technical Analysis

TrendNeutral
RSI49.6
Support$41.20
Resistance$44.06
MA 20$42.58
MA 50$42.85
MA 200$40.18
MACDBearish
VolumeStable
Fear & Greed Index89.18

Valuation

Target Price$46.13
Upside/Downside8.53%
GradeFair
TypeBlend
Dividend Yield2.16%

Risk Assessment

Beta-0.01
Volatility20.55%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.